Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Become a Member
Explore Different Ways to Give
Create a Legacy
Join IASLC's Partners for Thoracic Cancer Care
Recognizing Our Donors
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Education
Conferences & Education
Conferences
Webinars
Online Learning: Lung Cancer 360
Lung Cancer Considered Podcast
WCLC 2024
Science & Research
Science & Research
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Research Grant Program
Research Grant Program
Research Grant Recipients
IASLC Academy
Publications, Resources & Guidelines
Membership
Membership
Become a Member
Renew Your Membership
Early-Career Opportunities
Partners Society Membership Offers
Patients & Caregivers
Patients & Caregivers
STARS Training
Lung Cancer Awareness Month
News
News
IASLC Lung Cancer News
WCLC 2024 News
Press Releases
Search
Fulltext search
Fulltext search
Search
Displaying 13 - 23 items out of 23 results
ILCN article
The Rising Cost of Lung Cancer Therapies: What Are the Global Implications?
ILCN article
The Future Is Now: Pathology Is Going Digital
ILCN article
Enhancing Understanding of Testing Applications, Best Practices: A Q&A with Dr. Lynette M. Sholl
ILCN article
Low-Dose CT, ctDNA May Partner for Lung Cancer Detection
ILCN article
Award Lecture Highlights Tumor Evolution Through Liquid Biopsy
ILCN article
Optimal Pathologic Staging of Lung Cancer Depends on More Than the Pathologist
ILCN article
Histologic Evaluation of Lung Cancer Invasion: More Difficult Than Meets the Eye
ILCN article
Recurrence Remains a Risk Even for Patients Diagnosed via Screening
ILCN article
New Data Support Continued Use of IASLC Staging Model for Mesothelioma
ILCN article
Proposed Criteria for Tumor Invasion Align with Clinical Factors, Offer Better Predictability, Study Finds
ILCN article
Use of Predictive Biomarkers, Incorporating Chemotherapy—What Is Best When Using Immunotherapy in Advanced NSCLC?
Pagination
First
First page
‹
Previous page
1
2